ROK
67
5
LOW
58
2
NSC
64
2
SCHW
65
-2
SYF
93
-2
EXR
59
4
EMC
53
-3
STX
52
-4
UPS
50
9
JCI
61
-2
OMC
64
-2
HPE
70
2
EXPE
96
-3
DD
61
4
SHW
70
2
IP
70
-3
WDC
38
-3
MS
80
-3
NI
73
3
KSS
42
-3
ROK
67
5
LOW
58
2
NSC
64
2
SCHW
65
-2
SYF
93
-2
EXR
59
4
EMC
53
-3
STX
52
-4
UPS
50
9
JCI
61
-2
OMC
64
-2
HPE
70
2
EXPE
96
-3
DD
61
4
SHW
70
2
IP
70
-3
WDC
38
-3
MS
80
-3
NI
73
3
KSS
42
-3
Financhill
Back

The Oncology Institute 10K Form

Sell
25

TOI
The Oncology Institute

Last Price:
0.24
Seasonality Move:
-18.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TOI News And Ratings

See the #1 stock for the next 7 days that we like better than TOI

TOI Financial Statistics

Sales & Book Value

Annual Sales: $324.24M
Cash Flow: $-17.49M
Price / Cash Flow: 0
Annual Sales: $0.39
Price / Book: 0.74

Profitability

EPS (TTM): -0.79000
Net Income (TTM): $-71.54M
Gross Margin: $59.57M
Return on Equity: -125.91%
Return on Assets: -34.34%

The Oncology Institute Earnings Forecast

Key The Oncology Institute Financial Ratios

  • The Gross Profit Margin over the past 5 years for TOI is 18.37%.
  • The Selling, General & Administrative Expenses for TOI have been equal to 35.11% of Gross Profit Margin.
  • The Interest Expense is -8.16% of Operating Income.
  • The Net Earning history of TOI is -25.62% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

The Oncology Institute Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: TOI
Website: theoncologyinstitute.com

Debt

Debt-to-Equity Ratio: 3.08
Current Ratio: 3.31
Quick Ratio: 2.87

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TOI Technical Analysis vs Fundamental Analysis

Sell
25
The Oncology Institute (TOI) is a Sell

Is The Oncology Institute a Buy or a Sell?